INFI Overview
Upcoming Projects (INFI)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (INFI)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (INFI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (INFI)
-
NDA Filing for Duvelisib Projected Q1 of 2018
Tickers: VSTM, INFI
Occurred on: Feb 07, 2018 -
Phase 1 Expansion Cohorts of IPI-549 Expected to Initiate in the Second Half of 2017
Ticker: INFI
Occurred on: Aug 03, 2017 -
IPI-549 Monotherapy Dose Escalation expected to Complete in First Half of 2017
Ticker: INFI
Occurred on: Apr 01, 2017 -
Infinity (INFI) Presents Preclinical Data and Phase 1 Clinical Data on IPI-549 at PI3K Keystone Symposia Conference
Ticker: INFI
Occurred on: Jan 20, 2017 -
Infinity Announces Presentations On IPI-549 At Upcoming Immuno-Oncology Meeting
Ticker: INFI
Occurred on: Sep 26, 2016 -
Infinity Announces Publication On PI3K-Gamma In Nature
Ticker: INFI
Occurred on: Sep 19, 2016 -
Phase 1/2 initial data of Duvelisib - CONTEMPO trial for treatment-naive patients with follicular lymphoma due 2H 2016 -Study Withdrawn
Tickers: VSTM, INFI
Occurred on: Jun 29, 2016 -
Infinity Announces Presentations On Investigational Development Candidates, Duvelisib And IPI-549, At Upcoming EHA And ASCO Meetings
Ticker: INFI
Occurred on: Jun 20, 2016 -
Topline Data from DYNAMO Phase 2 Study of Duvelisib Due Q3 of 2016
Ticker: INFI
Occurred on: Jun 14, 2016 -
Infinity Advances IPI-549 to Phase 1 Study - Enrollment in Dose Escalation Study Began February 2016
Ticker: INFI
Occurred on: Feb 15, 2016
Strategic Initiatives (INFI)
-
Bristol-Myers Squibb (BMY) and Infinity Pharma (INFI) Announce Collaboration Agreement to Study Opdivo and IPI-549 in Patients with Advanced Solid Tumors
Tickers: INFI, BMY
Announcement Date: Nov 09, 2016
